🟢 Inovio Pharmaceuticals is trading 5% up in pre-market with no identified announcement explaining the pre-market rise

Inovio Pharmaceuticals is trading at $0.94, up 5.06% in pre-market, with no new company-specific announcement identified to explain the rise.

• The latest major company news remains the October 20 court judgment awarding $80,416,101; Inovio cautioned that the defendants’ financial condition may limit collection.
• Attention may be building ahead of the FDA’s October 30, 2026 target date for its INO-3107 application, though available reporting does not establish that this is driving today’s move.